K&F GROWTH ACQUISITION CORP. II

**Signal Note: Driehaus Capital Entry into KFIIU** Driehaus Capital's $7.7M initiation in K&F Growth Acquisition Corp. II signals conviction in an upcoming SPAC merger target within growth biotech, though the specific asset and indication remain undisclosed pending merger announcement. This move is notable given Driehaus's selective biotech allocation—the position size suggests material confidence in either a clinical-stage asset with near-term data readouts or a commercial-stage company with differentiated positioning. Key catalyst timing will depend on merger details and any associated clinical milestones or regulatory events for the target company.